Equity Details
Price & Market Data
Price: $4.75
Daily Change: $0.00 / 0.00%
Daily Range: $4.66 - $4.88
Market Cap: $450,683,392
Daily Volume: 509,147
Performance Metrics
1 Week: -8.30%
1 Month: -16.37%
3 Months: -26.24%
6 Months: 29.43%
1 Year: 283.1%
YTD: -9.35%
About Zura Bio Limited (ZURA)
Get up-to-date information on Zura Bio Limited (ZURA). The stock is trading at 4.75, with a daily performance indicating a change of $0.00 / 0.00%. Its market cap is recorded at 450,683,392. Delve into detailed performance metrics, from short-term (1-week) to long-term (1-year) and year-to-date returns.
Company Details
Employees: 40
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.